IL176762A0 - Pharmaceutical compositions comprising growth hormone and a statin - Google Patents

Pharmaceutical compositions comprising growth hormone and a statin

Info

Publication number
IL176762A0
IL176762A0 IL176762A IL17676206A IL176762A0 IL 176762 A0 IL176762 A0 IL 176762A0 IL 176762 A IL176762 A IL 176762A IL 17676206 A IL17676206 A IL 17676206A IL 176762 A0 IL176762 A0 IL 176762A0
Authority
IL
Israel
Prior art keywords
statin
pharmaceutical compositions
growth hormone
hormone
growth
Prior art date
Application number
IL176762A
Other languages
English (en)
Original Assignee
Deluca Giampiero
Serono Lab
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deluca Giampiero, Serono Lab, Applied Research Systems filed Critical Deluca Giampiero
Publication of IL176762A0 publication Critical patent/IL176762A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL176762A 2004-01-29 2006-07-10 Pharmaceutical compositions comprising growth hormone and a statin IL176762A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54020404P 2004-01-29 2004-01-29
US54336604P 2004-02-10 2004-02-10
PCT/EP2005/000758 WO2005074916A1 (en) 2004-01-29 2005-01-26 Methods and compositions for the treatment of lipodystrophy

Publications (1)

Publication Number Publication Date
IL176762A0 true IL176762A0 (en) 2006-10-31

Family

ID=34841102

Family Applications (1)

Application Number Title Priority Date Filing Date
IL176762A IL176762A0 (en) 2004-01-29 2006-07-10 Pharmaceutical compositions comprising growth hormone and a statin

Country Status (10)

Country Link
EP (1) EP1722778A1 (ja)
JP (1) JP2007519669A (ja)
KR (1) KR20060127977A (ja)
AU (1) AU2005210093A1 (ja)
BR (1) BRPI0507302A (ja)
CA (1) CA2552404A1 (ja)
EA (1) EA200601392A1 (ja)
IL (1) IL176762A0 (ja)
NO (1) NO20063279L (ja)
WO (1) WO2005074916A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2903312B1 (fr) 2006-07-05 2008-09-26 Univ Aix Marseille Ii Utilisation d'inhibiteurs d'hmg-coa reductase et de farnesyl-pyrophosphate synthase dans la preparation d'un medicament
AU2008353145B2 (en) * 2008-01-03 2013-09-12 Universite D' Aix-Marseille Bitherapy and tritherapy used for treating an HIV-positive patient
US20100267636A1 (en) * 2009-04-20 2010-10-21 Theratechnologies Inc. Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy
JP6712230B2 (ja) * 2014-03-11 2020-06-17 ノバルティス アーゲー リポジストロフィーおよびインスリン産生の欠損またはインスリンシグナル伝達の欠損と関連する代謝性障害を処置する方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803623D0 (sv) * 1998-10-22 1998-10-22 Sahltech Ab New therapeutic application

Also Published As

Publication number Publication date
WO2005074916A1 (en) 2005-08-18
NO20063279L (no) 2006-09-19
JP2007519669A (ja) 2007-07-19
KR20060127977A (ko) 2006-12-13
CA2552404A1 (en) 2005-08-18
EA200601392A1 (ru) 2006-12-29
EP1722778A1 (en) 2006-11-22
AU2005210093A1 (en) 2005-08-18
BRPI0507302A (pt) 2007-06-26

Similar Documents

Publication Publication Date Title
GB0413730D0 (en) A pharmaceutical composition and its use
IL179795A0 (en) A pharmaceutical composition and its use
ZA200606229B (en) A pharmaceutical composition
AU2003291103A8 (en) Pharmaceutical composition
IL177480A0 (en) Pharmaceutical composition
IL197889A (en) Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same
IL164547A0 (en) Pharmaceutical composition
IL183986A0 (en) Pharmaceutical compounds and compositions
IL178067A0 (en) Pharmaceutical dosage forms and compositions
IL165878A0 (en) Pharmaceutical composition
EP1496913A4 (en) NEUROPROTECTIVE PHARMACEUTICAL SPIROSTENOL COMPOSITIONS
GB2391809B (en) Pharmaceutical composition comprising honey
EP1765373A4 (en) OZONIZED PHARMACEUTICAL COMPOSITION AND METHOD THEREOF
PL1802329T3 (pl) Formulacja farmaceutyczna zawierająca krystaliczną insulinę oraz rozpuszczoną insulinę
ZA200704926B (en) Modified human growth hormone
IL176762A0 (en) Pharmaceutical compositions comprising growth hormone and a statin
GB2411355B (en) Pharmaceutical composition
EP1803452A4 (en) ESTER DERIVATIVE AND ITS PHARMACEUTICAL USE THEREOF
GB0400452D0 (en) A pharmaceutical composition
ZA200701932B (en) Pharmaceutical composition
GB0425255D0 (en) Pharmaceutical composition
EP1809298A4 (en) NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS CONTAINING SPIROSTENOL
HK1065477A1 (en) Pharmaceutical composition
GB0406014D0 (en) Pharmaceutical composition and use
GB0217703D0 (en) Pharmaceutical composition